Clinical Trial Update: An Ophthalmic Safety Study in Patients With Breast Cancer

View source ↗

Summary

AstraZeneca is conducting an ophthalmic safety study in patients with breast cancer, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Ophthalmic Safety in Patients With Breast Cancer | Status: RECRUITING